TCMBANKIN005275 |
25-o-methylcimigenol |
|
C31H50O5 |
|
CC1CC2C(OC3(C1C4(CCC56CC57CCC(C(C7CCC6C4(C3O)C)(C)C)O)C)O2)C(C)(C)OC |
TCMBANKIN026488 |
25-o-acetyl-7,8-didehydrocimigenol |
25-o-acetyl-7, 8-didehydrocimigenol |
|
|
|
TCMBANKIN026723 |
2,7-Dideacetyl-2,7-dibenzoyl-taxayunnanine F |
2,7-dideacetyl-2,7-dibenzoyl-taxayunnanine f |
C40H46O13 |
776.9 |
CC1=C2C(C(C3(C(CC4C(C3C(C2(CC1OC(=O)C)C(C)(C)O)OC(=O)C5=CC=CC=C5)(CO4)OC(=O)C)OC(=O)C6=CC=CC=C6)C)OC(=O)C)OC(=O)C |
TCMBANKIN042259 |
cimigenol |
3779-59-7; 11-(2-Hydroxypropan-2-yl)-1,1,7a,8,13a-pentamethyloctadecahydro-5H-10,12a-epoxycyclopropa[1',8a']naphtho[2',1':4,5]indeno[2,1-b]oxepine-2,13-diol; SCHEMBL12536213; DTXSID70634573 |
C31H50O4 |
487 |
C1([H])([H])C([H])([H])[C@]2([C@](C2([H])[H])(C([H])([H])C([H])([H])[C@](C([H])([H])[H])([C@]3([H])[C@@]4(O[C@@]([H])([C@](C(C([H])([H])[H])(O[H])C([H])([H])[H])([H])C4([H])[H])C([H])([H])[C@]3(C([H])
([H])[H])[H])[C@@]5(O[H])[H])[C@@]56C([H])([H])[H])[C@@]6([H])C([H])([H])C7([H])[H])[C@]7([H])C(C([H])([H])[H])(C([H])([H])[H])[C@@]1([H])O[H] |
TCMBANKIN042991 |
cimiracemoside h |
|
C37H58O11 |
678.8 g/mol |
CC1C2C(CC3(C2(C(CC45C3CCC6C4(C5)CCC(C6(C)C)OC7C(C(C(CO7)O)O)O)OC(=O)C)C)C)OC8(C1OC(C8O)(C)C)O |
TCMBANKIN046732 |
23-O-acetylshengmanol-3-O-alpha-L-arabinopyranoside |
23-o-acetylshengmanol 3-o-α-l-arabinopyrano-side |
C37H58O10 |
663 |
C1([H])([H])O[C@@]([H])(O[C@]2([H])C(C([H])([H])[H])(C([H])([H])[H])[C@@]3([H])[C@@]4([C@@]5(C4([H])[H])[C@]([H])([C@](C([H])([H])[H])([C@@]([H])(O[H])C(=O)[C@]6([H])[C@]([H])(C([H])([H])[H])C([H])([H
])[C@@]([H])(OC(=O)C([H])([H])[H])[C@]7([H])OC7(C([H])([H])[H])C([H])([H])[H])[C@]6(C([H])([H])[H])C([H])([H])C5([H])[H])C([H])([H])C3([H])[H])C([H])([H])C2([H])[H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]
1([H])O[H] |
TCMBANKIN047255 |
Cimiracemoside E |
|
|
678.8 g/mol |
|
TCMBANKIN048529 |
Cimiracemoside F |
|
|
676.8 g/mol |
|
TCMBANKIN048725 |
cimiracemoside g |
|
C37H56O11 |
676.8 g/mol |
CC1C2C(CC3(C2(C(CC45C3=CCC6C4(C5)CCC(C6(C)C)OC7C(C(C(CO7)O)O)O)OC(=O)C)C)C)OC8(C1OC(C8O)(C)C)O |
TCMBANKIN049919 |
Actein |
|
|
677 |
|
TCMBANKIN059555 |
2α, 3β, 23-trihydroxyurs-5, 12-dien-28-oic acid |
|
C35H56O11 |
|
CC1(C2CCC3C4(C(C56C(C4(C(CC37C2(C7)CCC1OC8C(C(C(CO8)O)O)O)O)C)C(CC(O5)C(O6)C(C)(C)O)CO)O)C)C |
TCMBANKIN060435 |
cimiside a |
|
C35H56O10 |
636.8 g/mol |
CC1CC2C(OC3(C1C4(C(CC56CC57CCC(C(C7CCC6C4(C3O)C)(C)C)OC8C(C(C(CO8)O)O)O)O)C)O2)C(C)(C)O |
TCMBANKIN061469 |
isoferulic acid |
4CH-004345; KBio3_001774; NSC-51987; 4FE; Spectrum3_000887; 25522-33-2; ST098721; FCH3451845; AX8011852; 537-73-5; V0307; CHEBI:27794; Bio-0194; 3-Hydroxy-4-methoxycinnamate; KBio2_004107; CS-W020120; (E)-3'-Hydroxy-4'-methoxycinnamic acid; ZINC156055; 3-Hydroxy-4-methoxycinnamic acid; BRN 2212760; M-2347; SpecPlus_000233; 2-Propenoic acid,3-(3-hydroxy-4-methoxyphenyl)-, (2E)-; C10470; SCHEMBL249041; N1393; 4-10-00-01777 (Beilstein Handbook Reference); QURCVMIEKCOAJU-HWKANZROSA-N; XSQ2K2G7MC; 3-Hydroxy-4-methoxycinnamic acid, predominantly trans, 97%; EINECS 208-676-0; Spectrum4_000979; 3-(3-Hydroxy-4-methoxyphenyl)acrylic acid; NCGC00247490-01; 3-hydroxy-4-methoxy-Cinnamate; 3-(3-Hydroxy-4-methoxyphenyl)-2-propenoic acid; AK676011; AM20040660; Isoferulate; 2-Propenoic acid, 3-(3-hydroxy-4-methoxyphenyl)-, (2E)-; 3-(3-hydroxy-4-methoxy-phenyl)acrylic acid; (E)-3-(3-hydroxy-4-methoxyphenyl)acrylic acid; AC1LEHK0; PubChem8187; ST2404733; Cinnamic acid, 3-hydroxy-4-methoxy-; 2-Hydoxy-4-methoxy-5-sulfobenzophenone; KBioSS_001539; UNII-XSQ2K2G7MC; TX-011905; 3-Hydroxy-4-methoxycinnamic acid, predominantly trans; 3-hydroxy-4-methoxy-cinnamic acid; 3-(3-hydroxy-4-methoxyphenyl)prop-2-enoic acid; Z2693271860; HMS2268G06; BG01510484; SMR001215828; GTPL7980; ST5135831; 103012_ALDRICH; BBV-025077; BDBM50241245; SC-05161; (E)-3-(3-hydroxy-4-methoxyphenyl)prop-2-enoic acid; AC1Q4691; MolPort-000-490-526; (E)-3-(3-hydroxy-4-methoxy-phenyl)-acrylic acid; CI-177; isoferulic acid ; KBio2_006675; AX8329161; AC1Q5T96; MFCD00004391; EINECS 247-071-6; DivK1c_006329; Q-100609; AC1Q5RAQ; FCH089654; Hesperetic acid; 537H735; KBio1_001273; KBioGR_001357; AK-88788; MLS000563054; Hesperetate; I01-2711; bmse000618; trans-Isoferulic acid, analytical standard; (2E)-3-(3-hydroxy-4-methoxyphenyl)prop-2-enoic acid; Spectrum_001059; AKOS000141174; (E)-3-(3-hydroxy-4-methoxy-phenyl)acrylic acid; RP25302; Cinnamic acid, 3-hydroxy-4-methoxy- (8CI); STR05122; SBB042817; Isoferulasaure; MS-11465; AB0019799; D04EWW; Isoferulic acid; 3-(3-hydroxy-4-methoxy-phenyl)prop-2-enoic acid; 3-Hydroxy-4-methoxycinnamic-acid; (2E)-3-(3-Hydroxy-4-methoxyphenyl)-2-propenoic acid #; (E)-3-(3-hydroxy-4-methoxy-phenyl)prop-2-enoic acid; AC1Q4690; NSC51987; AJ-13677; KBio2_001539; Hespertitinic acid; NSC 51987; DB07109; EN300-50983; SCHEMBL249042; 2-Propenoic acid, 3-(3-hydroxy-4-methoxyphenyl)-; CHEMBL233295; KB-182983; 3-(3-hydroxy-4-methoxyphenyl)-2-Propenoate; MCULE-7013523945;hespereticacid |
C10H10O4 |
194.18 |
COC1=C(C=C(C=C1)C=CC(=O)O)O |